Skip to main content
Figure 1 | Arthritis Research & Therapy

Figure 1

From: Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports

Figure 1

Scatter plot of trials comparing celecoxib with NSAID for discontinuations due to gastrointestinal adverse events. Celecoxib at any dose is represented. The red symbol represents the longest trial, at 52 weeks. GI, gastrointestinal; NSAID, nonsteroidal anti-inflammatory drug.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us